These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 7830580)

  • 1. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.
    Belland RJ; Morrison SG; Ison C; Huang WM
    Mol Microbiol; 1994 Oct; 14(2):371-80. PubMed ID: 7830580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998.
    Su X; Lind I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):117-23. PubMed ID: 11120953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
    Shultz TR; Tapsall JW; White PA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.
    Tanaka M; Takahashi K; Saika T; Kobayashi I; Ueno T; Kumazawa J
    J Urol; 1998 Jun; 159(6):2215-9. PubMed ID: 9598572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
    Heisig P
    Antimicrob Agents Chemother; 1996 Apr; 40(4):879-85. PubMed ID: 8849244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
    Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
    Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS; Fisher LM
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae.
    Lindbäck E; Rahman M; Jalal S; Wretlind B
    APMIS; 2002 Sep; 110(9):651-7. PubMed ID: 12529019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
    Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
    BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
    Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
    Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
    Chaudhry U; Ray K; Bala M; Saluja D
    Sex Transm Infect; 2002 Dec; 78(6):440-4. PubMed ID: 12473806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.
    Zhou W; Du W; Cao H; Zhao J; Yang S; Li W; Shen Y; Zhang S; Du W; Zhang X
    J Clin Microbiol; 2004 Dec; 42(12):5819-24. PubMed ID: 15583317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and the United States.
    Trees DL; Sandul AL; Peto-Mesola V; Aplasca MR; Leng HB; Whittington WL; Knapp JS
    Int J Antimicrob Agents; 1999 Aug; 12(4):325-32. PubMed ID: 10493609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Ezaki T; Saito I; Kawada Y
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1020-3. PubMed ID: 8849219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
    Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
    Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.
    Okuda J; Hayakawa E; Nishibuchi M; Nishino T
    Antimicrob Agents Chemother; 1999 May; 43(5):1156-62. PubMed ID: 10223929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.
    Kulkarni S; Bala M; Sane S; Pandey S; Bhattacharya J; Risbud A
    Int J Antimicrob Agents; 2012 Dec; 40(6):549-53. PubMed ID: 23063097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.
    Muñoz R; De La Campa AG
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2252-7. PubMed ID: 8891124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.